These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


421 related items for PubMed ID: 32983330

  • 1. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results.
    Maurer M, Giménez-Arnau A, Ensina LF, Chu CY, Jaumont X, Tassinari P.
    World Allergy Organ J; 2020 Sep; 13(9):100460. PubMed ID: 32983330
    [Abstract] [Full Text] [Related]

  • 2. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H1-Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study.
    Chu CY, Al Hammadi A, Agmon-Levin N, Atakan N, Farag A, Arnaout RK, Kannenberg S, Kulthanan K, Mubarak A, Zaitoun F, Crowe S, Malfait S, Cooke K, Dekker EL.
    World Allergy Organ J; 2020 Apr; 13(4):100117. PubMed ID: 32382379
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
    Maurer M, Raap U, Staubach P, Richter-Huhn G, Bauer A, Oppel EM, Hillen U, Baeumer D, Reinhardt M, Chapman-Rothe N.
    Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria.
    Kocatürk E, Kızıltaç U, Can P, Öztaş Kara R, Erdem T, Kızıltaç K, Sahillioğlu N, Gelincik A, Maurer M, Weller K.
    World Allergy Organ J; 2019 May; 12(1):100009. PubMed ID: 30937134
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.
    Yang, Yu R, Qian W, Zheng Q, Xiong J, Chen S, Chen A, Chen J, Fang S, Huang K, Cai T.
    Int Arch Allergy Immunol; 2023 May; 184(7):643-655. PubMed ID: 36996780
    [Abstract] [Full Text] [Related]

  • 17. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience.
    Gimenez-Arnau A, Bartra J, Ferrer M, Jauregui I, Borbujo J, Figueras I, Muñoz-Bellido FJ, Pedraz J, Serra-Baldrich E, Tejedor-Alonso MA, Velasco M, Terradas P, Labrador M.
    J Investig Allergol Clin Immunol; 2022 Jun 20; 32(3):191-199. PubMed ID: 33349612
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea.
    Ye YM, Koh YI, Choi JH, Kim MA, Park JW, Kim TB, Nam YH, Chang YS, Park HS.
    Korean J Intern Med; 2022 Sep 20; 37(5):1050-1060. PubMed ID: 36068718
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.